Mosaic ImmunoEngineering Inc (CPMV)

[2bStealthy]

The subject annual report, semi-annual report, transition report on Form 10-K, 10-KSB, 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, 10-QSB or portion thereof will be filed on or before the fifth calendar day following that prescribed due date;
and

The Company requires additional time to consider new information related
to (a) the accounting treatment of convertible debentures issued during
recent years, which are no longer outstanding, and (b) the method of
presenting the financial results of Phoenix Digital Solutions, f.k.a.
P-Newco, a limited liability company which is 50% owned by the Company.